Paramasivam Prabu
Overview
Explore the profile of Paramasivam Prabu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monisha K, Mahema S, Chokkalingam M, Ahmad S, Emran T, Prabu P, et al.
Biomedicines
. 2023 Nov;
11(11).
PMID: 38001953
A proinflammatory role of has been implicated in the pathogenesis of atherosclerosis as an emerging novel epigenetic diagnostic biomarker. However, its association with the clinical and cardiovascular function in coronary...
2.
Anirudhan A, Prabu P, Sanyal J, Banerjee T, Guha G, Murugesan R, et al.
NPJ Parkinsons Dis
. 2021 Jan;
7(1):3.
PMID: 33398051
Metalloproteins utilizes cellular metals which plays a crucial function in brain that linked with neurodegenerative disorders. Parkinson's disease (PD) is a neurodegenerative disorder that affects geriatric population world-wide. Twenty-four metal-binding...
3.
Monisha K, Prabu P, Chokkalingam M, Murugesan R, Milenkovic D, Ahmed S
Sci Rep
. 2020 Oct;
10(1):16359.
PMID: 33004884
Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular...
4.
Parmar D, Bhattacharya N, Kannan S, Vadivel S, Pandey G, Ghanate A, et al.
Sci Rep
. 2020 Feb;
10(1):2970.
PMID: 32076062
Altered circulatory asymmetric and symmetric dimethylarginines have been independently reported in patients with end-stage renal failure suggesting their potential role as mediators and early biomarkers of nephropathy. These alterations can...
5.
Prabu P, Poongothai S, Shanthirani C, Anjana R, Mohan V, Balasubramanyam M
Acta Diabetol
. 2020 Feb;
57(7):799-807.
PMID: 32025863
Aims: Several studies have reported the role of biomarkers either in diabetes or depression. The present study is aimed at profiling the circulating levels of miR-128, brain-derived neurotrophic factor (BDNF),...
6.
Soundararajan A, Prabu P, Mohan V, Gibert Y, Balasubramanyam M
Mol Cell Biochem
. 2019 Apr;
458(1-2):171-183.
PMID: 31004310
There is a striking interaction of genes and environment in the etiology of type 2 diabetes mellitus (T2DM). While endocrine disrupting chemicals (EDCs) like bisphenol-A (BPA) have received special attention...
7.
Sathishkumar C, Prabu P, Mohan V, Balasubramanyam M
Hum Genomics
. 2018 Aug;
12(1):41.
PMID: 30139387
Background: Studying epigenetics is expected to provide precious information on how environmental factors contribute to type 2 diabetes mellitus (T2DM) at the genomic level. With the progress of the whole-genome...
8.
Sathishkumar C, Prabu P, Balakumar M, Lenin R, Prabhu D, Anjana R, et al.
Clin Epigenetics
. 2016 Dec;
8:125.
PMID: 27904654
Background: A role of proinflammation has been implicated in the pathogenesis of diabetes, but the up-stream regulatory signals and molecular signatures are poorly understood. While histone modifications such as changes...
9.
Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, et al.
Eur J Nutr
. 2016 Oct;
57(1):279-295.
PMID: 27757592
Purpose: Diabetes and obesity are characterized by glucose intolerance, fat deposition, inflammation, and dyslipidemia. Recent reports postulated that distinct gut microbiota alterations were observed in obese/diabetic subjects and modulating gut...
10.
Prabu P, Rome S, Sathishkumar C, Aravind S, Mahalingam B, Shanthirani C, et al.
PLoS One
. 2015 May;
10(5):e0128372.
PMID: 26020947
Several omics technologies are underway worldwide with an aim to unravel the pathophysiology of a complex phenotype such as type 2 diabetes mellitus (T2DM). While recent studies imply a clinically...